Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Pediatrics. 2019 Sep 16;144(4):e20190896. doi: 10.1542/peds.2019-0896

Table 1.

Prevalence rates of off-label systemic drug orders in ambulatory pediatric visits in the United States (2006–2015)1

Off-label characteristic Sample N % of total visits (95% CI) % of visits with systemic drugs (95% CI) % of off-label or possibly off-label drugs (95% CI) Estimated orders, millions/year (95% CI)
Off-label for any reason 17,064 18.5 (17.7–19.3) 44.5 (43.3, 45.8) 90.6 (89.8, 91.4) 41.2 (39.9, 42.4)
Possibly off-label for any reason 1,801 1.6 (1.5, 1.8) 3.9 (3.5, 4.4) 9.4 (8.6, 10.2) 4.3 (3.9, 4.7)
 Off-label by indication 13,914 15.6 (15.0, 16.3) 37.6 (36.4, 38.8) 74.6 (73.2, 75.9) 33.9 (32.7, 35.1)
 Possibly off-label by indication 2,079 1.8 (1.7, 2.0) 4.4 (4.0, 4.9) 10.2 (9.5, 11.1) 4.6 (4.3, 5.1)
 Off-label by age 3,501 4.3 (3.9, 4.6) 10.3 (9.6, 11.0) 17.6 (16.5, 18.7) 8.0 (7.4, 8.6)
 Off-label by weight 131 0.2 (0.2, 0.3) 0.6 (0.4, 0.8) 0.6 (0.4, 0.8) 0.4 (0.3, 0.6)
 Possibly off-label by weight 419 0.5 (0.4, 0.6) 1.2 (1.0, 1.5) 1.2 (0.9, 1.5) 0.9 (0.7, 1.1)
 Off-label by combination of age, indication, and (where applicable) weight2 893 1.2 (1.0, 1.4) 2.8 (2.5, 3.3) 4.6 (4.1, 5.3) 2.1 (1.8, 2.4)
1

All rates account for sampling, clustering, and strata, reflecting nationally representative estimates

2

Drugs that were ordered for an approved indication, an approved age (and, where applicable, weight) for a different indication, but an unapproved age or weight for the documented diagnoses and symptoms